Search

Your search keyword '"Jiang, X. G."' showing total 35 results

Search Constraints

Start Over You searched for: Author "Jiang, X. G." Remove constraint Author: "Jiang, X. G."
35 results on '"Jiang, X. G."'

Search Results

7. Correlative study on risk factors of depression among acute stroke patients.

15. [Outcomes at discharge of preterm infants born <34 weeks' gestation].

16. [The predictive value of ultrasonic measurement of the diaphragmatic thickening fraction combined with the maximal inspiratory pressure in mechanical ventilation patients].

17. Analysis of volatile species kinetics during typical medical waste materials pyrolysis using a distributed activation energy model.

18. Study on pyrolysis of typical medical waste materials by using TG-FTIR analysis.

19. Intranasal absorption of rizatriptan--in vivo pharmacokinetics and bioavailability study in humans.

20. The methodology of corpus cavernosum electromyography revisited.

21. A validated HPLC-ESI-MS method for the determination of loratadine in human plasma and its application to pharmacokinetic studies.

22. The value of corpus cavernosum electromyography in erectile dysfunction: current status and future prospect.

23. Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.

24. Lowering of sodium deoxycholate-induced nasal ciliotoxicity with cyclodextrins.

26. Relationship between plasma D(-)-lactate and intestinal damage after severe injuries in rats.

27. [Typing of H. pylori strains isolated from patients with gastric diseases].

28. [Studies on octanol-water partition coefficient and nasal drug absorption].

29. [Studies on HPLC method for determination of 4-methylaminoantipyrine and relative bioavailabilities of analgin nasal drops in human volunteers].

30. [A comparison of purified urease antigen and whole cell antigen of Helicobacter pylori by ELISA test--study on the application and serum diagnoses of Helicobacter pylori urease diagnostic reagent].

31. [Toxicity of drugs on nasal mucocilia and the method of its evaluation].

32. [Comparison of concentration of piroxicam in blood and local site after two routes of administration].

33. [A reversed-phase HPLC method for determining tretinoin].

34. [A HPLC method for determining piroxicam in body fluids].

35. [Effect of enhancers on cutaneous permeation of piroxicam in vitro].

Catalog

Books, media, physical & digital resources